A clinical prognostic index for assessing patients aged > 60 being considered for high-dose therapy and autologous stem-cell transplant in relapsed or refractory high-grade non-Hodgkin lymphoma
BONE MARROW TRANSPLANTATION（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要